KZR-504 is a highly selective inhibitor of immunoproteasome low molecular mass polypeptide 2 (LMP2) , with IC 50 s of 51 nM, 4.274 μM for LMP2 and LMP7, respectively. KZR-504 is of interest for the treatment of autoimmune disease
In Vivo
Evaluating the inhibition of LMP2, and antitargets LMP7 and β5, in mouse tissues reveals that KZR-504 (compound 12) is both selective and potent in vivo with >50% target inhibition achieved at >1 mg/kg in all tissues tested except brain . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:IC50: 51 nM (LMP2), 4.274 μM (LMP7)
规格
规格或纯度
≥98%
英文名称
KZR-504
生化机理
KZR-504 是免疫蛋白酶体低分子质量多肽 2 (LMP2) 的高选择性抑制剂,对 LMP2 和 LMP7 的 IC 50 s 分别为 51 nM 和 4.274 μM。KZR-504 可用于治疗自身免疫性疾病。